{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:28:58Z","timestamp":1786354138688,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Cancer-associated thrombosis is a clinically important complication of malignancy. The systemic immune\u2013inflammation index (SII), calculated from platelet, neutrophil, and lymphocyte counts, may reflect the inflammatory background of cancer, but its value in matched heterogeneous cancer cohorts remains unclear. Objective: To evaluate whether SII is associated with thrombotic status and recorded all-cause mortality in patients with solid cancers. Methods: This retrospective matched cohort study was derived from 2020 consecutive adult patients hospitalized with solid malignancies between September 2023 and December 2025 at the Oncology Clinic of University Hospital \u201cTsaritsa Yoanna\u2014ISUL\u201d, Sofia, Bulgaria. Patients with documented thrombosis were matched 1:2 to non-thrombotic controls using a nearest propensity-score approach, with preference for exact matching on sex and cancer type. The final cohort included 110 thrombotic patients and 220 matched controls. SII was analyzed in relation to thrombotic status and recorded all-cause mortality using logistic regression. Results: Thrombotic patients and controls were well balanced for matching variables. Mortality was similar between groups: 29.1% versus 28.2%. SII did not differ significantly between thrombotic patients and controls: 772 (516\u20131471) versus 783 (501\u20131292), p = 0.655, and showed poor discrimination for thrombotic status, with an AUC of 0.515. In the overall matched cohort, higher SII was associated with recorded all-cause mortality after adjustment for thrombotic status, age, sex, cancer type, stage, and metastatic disease: OR 1.31 per 1000-unit increase, 95% CI 1.05\u20131.64, p = 0.016. The association was numerically stronger among thrombotic patients, but interaction testing was not statistically significant. Conclusions: SII was not associated with thrombotic status in this matched cancer cohort. Higher SII was associated with recorded all-cause mortality, suggesting that SII may better reflect systemic inflammatory burden than cancer-associated thrombosis itself.<\/jats:p>","DOI":"10.3390\/diseases14080285","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:20:03Z","timestamp":1786324803000},"page":"285","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Immune\u2013Inflammation Index, Thrombotic Status, and Mortality in Patients with Cancer: A Matched Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8447-1390","authenticated-orcid":false,"given":"Bozhidar","family":"Krastev","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Medical University of Sofia, 1527 Sofia, Bulgaria"},{"name":"Clinic of Cardiology, University Hospital \u201cTsaritsa Yoanna-ISUL\u201d, 1527 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Spasova","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Medical University of Sofia, 1527 Sofia, Bulgaria"},{"name":"Clinic of Cardiology, University Hospital \u201cTsaritsa Yoanna-ISUL\u201d, 1527 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9925-9025","authenticated-orcid":false,"given":"Georgi","family":"Dimitrov","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Medical University of Sofia, University Hospital \u201cTsaritsa Yoanna-ISUL\u201d, 1527 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9935-720X","authenticated-orcid":false,"given":"Elena","family":"Kinova","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Medical University of Sofia, 1527 Sofia, Bulgaria"},{"name":"Clinic of Cardiology, University Hospital \u201cTsaritsa Yoanna-ISUL\u201d, 1527 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assen","family":"Goudev","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Medical University of Sofia, 1527 Sofia, Bulgaria"},{"name":"Clinic of Cardiology, University Hospital \u201cTsaritsa Yoanna-ISUL\u201d, 1527 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,9]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2026, June 07). Cancer, Available online: https:\/\/www.who.int\/health-topics\/cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau\u2019s syndrome: Multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","article-title":"Thrombocytosis associated with malignant disease","volume":"114","author":"Levin","year":"1964","journal-title":"Arch. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","article-title":"Paraneoplastic thrombocytosis in ovarian cancer","volume":"366","author":"Stone","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2016.06.033","article-title":"Epidemiology of venous thromboembolism in the Framingham Heart Study","volume":"145","author":"Puurunen","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: A population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0049-3848(16)30092-5","article-title":"Cancer associated thrombosis: Risk factors and outcomes","volume":"140","author":"Eichinger","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: Results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109243","DOI":"10.1016\/j.thromres.2024.109243","article-title":"Thromboembolic events associated with immune checkpoint inhibitors in cancer patients: A Bayesian network meta-analysis","volume":"246","author":"Lin","year":"2025","journal-title":"Thromb. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zahir, M.N., Shaikh, Q., Shabbir-Moosajee, M., and Jabbar, A.A. (2017). Incidence of venous thromboembolism in cancer patients treated with cisplatin based chemotherapy: A cohort study. BMC Cancer, 17.","DOI":"10.1186\/s12885-016-3032-4"},{"key":"ref_12","first-page":"221","article-title":"Thromboembolic events associated with bevacizumab plus chemotherapy for patients with colorectal cancer: A meta-analysis of randomized controlled trials","volume":"9","author":"Alahmari","year":"2016","journal-title":"Am. Health Drug Benefits"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12959-025-00719-7","article-title":"Cancer-associated venous thromboembolism: A comprehensive review","volume":"23","author":"Wan","year":"2025","journal-title":"Thromb. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2014-08-531582","article-title":"Platelets at the interface of thrombosis, inflammation, and cancer","volume":"126","author":"Franco","year":"2015","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.7150\/jca.25691","article-title":"Prognostic value of systemic immune-inflammation index in cancer: A meta-analysis","volume":"9","author":"Yang","year":"2018","journal-title":"J. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"75381","DOI":"10.18632\/oncotarget.18856","article-title":"Prognostic role of systemic immune-inflammation index in solid tumors: A systematic review and meta-analysis","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, G., Bao, B., Ye, Y., Hu, A., Sun, J., and Liu, W. (2025). Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1532343"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","article-title":"Biomarkers for prediction of venous thromboembolism in cancer","volume":"122","author":"Pabinger","year":"2013","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: A development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9215311","DOI":"10.1155\/2022\/9215311","article-title":"The diagnostic value of the systemic immune-inflammation index for venous thromboembolism in lung cancer patients: A retrospective study","volume":"2022","author":"Zhang","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Chen, H., Liu, J., Zhang, Q., Xu, Y., and Liu, J. (2026). Systemic immune-inflammation index as a predictor of venous thromboembolism in NSCLC patients treated with ICIs: A retrospective study. BMC Pulm. Med., 26.","DOI":"10.1186\/s12890-025-04061-6"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.2147\/JIR.S376601","article-title":"The efficacy of the systemic immune-inflammation index and prognosis nutritional index for the diagnosis of venous thromboembolism in gastrointestinal cancers","volume":"15","author":"Zhang","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"\u00d6zcan, P., and D\u00fczg\u00fcn, \u00d6. (2024). The importance of preoperative NLR, PLR, and MPV values in predicting the risk of complications in colorectal peritoneal carcinomatosis. J. Pers. Med., 14.","DOI":"10.20944\/preprints202407.1091.v1"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/8\/285\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:39:59Z","timestamp":1786351199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/8\/285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,9]]},"references-count":24,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["diseases14080285"],"URL":"https:\/\/doi.org\/10.3390\/diseases14080285","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,9]]}}}